Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models
Science Translational Medicine · 2026
DOI: 10.1126/scitranslmed.ady0403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Hoi Kiu Wong und 25 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Neuroimmunology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, 81377 Munich, Germany. Hauptthemen laut MEDLINE: Neuromyelitis Optica, Astrocytes, Autoantibodies, Membrane Proteins. Die Arbeit nennt 80 Literaturangaben. Gefördert von: National Institute of Neurological Disorders and Stroke, Deutsche Forschungsgemeinschaft, DFG.
Abstract (Originalsprache)
The identification of autoantibodies against aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) has been essential in distinguishing neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody–associated disease (MOGAD) from classical multiple sclerosis (MS), with important implications for treatment. However, for several patients within this disease spectrum, the target of the autoimmune response remains unknown. Here, we describe the modulator of VRAC current 1 (MLC1), a membrane protein with extracellular epitopes enriched at astrocytic end feet, as an autoantigen. Serum MLC1 antibodies were verified with a cell-based assay, identifying four MLC1 immunoglobulin G (IgG)–positive patients among 297 patients with inflammatory autoimmune diseases of the central nervous system who were screened. All four MLC1 IgG–positive patients exhibited overlapping yet atypical clinical features of MS and NMOSD and tested negative for AQP4 and MOG antibodies. Moreover, treatment with a monoclonal MLC1 antibody induced astrocytopathy in mouse cerebellar slice cultures and in a rat encephalitis model. Thus, MLC1 antibodies identify a subset of patients with an NMOSD-like phenotype, underscoring their potential as a disease marker with pathogenic relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Neuroimmunology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
- Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universität München, 82152 Planegg-Martinsried, Germany.
- Graduate School of Systemic Neuroscience, Ludwig-Maximilians-Universität München, 82152 Planegg-Martinsried, Germany.
- Division of Neuroimmunology, Center for Brain Research, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Neurology, University of Colorado Denver Anschutz Medical Center, Aurora, CO 80045, USA.
- Department of Translational Immunology, Department of Medicine 3-Rheumatology and Immunology, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erla…
ORCID-Profile: Hoi Kiu Wong, Samantha Ho, Qian Yu, Dorina Shqau, Selia Baier, Stephan Winklmeier, Arek Kendirli, Kathrin Schanda, Eva Oswald, Katharina Bräuer, Franziska S Thaler, Lisa Ann Gerdes, Regina Feederle, Martin Kerschensteiner, Markus Reindl, Mohsen Khademi, Fredrik Piehl, Tomas Olsson, Jeffrey L Bennett, Tania Kümpfel, Naoto Kawakami, Monika Bradl, Edgar Meinl, Simone Mader
Förderung
- National Institute of Neurological Disorders and Stroke
- Deutsche Forschungsgemeinschaft
- DFG
- Else Kröner Fresenius Stiftung
- The Guthy-Jackson Charitable Foundation
- Schering Stiftung and the Fritz Thyssen Foundation
- the Verein zur Therapieforschung für MS Kranke
- Austrian Science FWF
Zitieren
APA
Wong, H. K., Ho, S., Yu, Q., Given, K. S., Shqau, D., Baier, S., Winklmeier, S., Rübsamen, H., Kendirli, A., Schanda, K., Oswald, E., Bräuer, K., Thaler, F. S., Gerdes, L. A., Feederle, R., Kerschensteiner, M., Reindl, M., Khademi, M., Piehl, F., …, & Mader, S. (2026). Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ady0403
Vancouver
Wong HK, Ho S, Yu Q, Given KS, Shqau D, Baier S, et al. Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.ady0403
BibTeX
@article{Wong2026,
author = {Wong, Hoi Kiu and Ho, Samantha and Yu, Qian and Given, Katherine S and Shqau, Dorina and Baier, Selia and Winklmeier, Stephan and Rübsamen, Heike and Kendirli, Arek and Schanda, Kathrin and Oswald, Eva and Bräuer, Katharina and Thaler, Franziska S and Gerdes, Lisa Ann and Feederle, Regina and Kerschensteiner, Martin and Reindl, Markus and Khademi, Mohsen and Piehl, Fredrik and Olsson, Tomas and Bennett, Jeffrey L and Kümpfel, Tania and Kawakami, Naoto and Bradl, Monika and Meinl, Edgar and Mader, Simone},
title = {Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models},
journal = {Science Translational Medicine},
year = {2026},
doi = {10.1126/scitranslmed.ady0403}
}
EUVIMED